Constellation Pharmaceuticals Inc Watch

from 10-K 89 pages Lease Agreement

from 10-Q 4 pages Material contract

from 10-Q 10 pages Consulting Agreement

from 8-K 28 pages Registration Rights Agreement

from 8-K 40 pages Securities Purchase Agreement

from 10-Q 5 pages Fifth Amendment to Lease

from 8-K 81 pages Agreement

from 10-Q 7 pages Fourth Amendment to Lease

from 10-Q 7 pages June 28, 2018 Adrian Senderowicz, MD Dear Adrian, You Are Employed by Constellation Pharmaceuticals, Inc., a Delaware Corporation (The “Company”) Pursuant to That Certain Offer Letter, by and Between You and the Company Dated July 6, 2017 (The “Original Offer Letter”)

from S-1/A 97 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. License and Collaboration Agreement Between Genentech, Inc., F. Hoffmann-La Roche Ltd and Constellation Pharmaceuticals, Inc

from S-1 16 pages Indemnification Agreement

from S-1 5 pages Consulting Agreement

from S-1 5 pages Consulting Agreement

from S-1 12 pages Constellation Pharmaceuticals, Inc. Amended and Restated Change in Control Severance Plan , 2018

from S-1 7 pages Material contract

from S-1 7 pages August 30, 2017 Emma Reeve Dear Emma, It Is My Pleasure to Confirm Our Offer to You for the Position of Sr. Vice President & Chief Financial Officer at Constellation Pharmaceuticals, Inc. (“The Company”). This Letter and Accompanying Enclosures Will Summarize Important Details About Your Employment

from S-1 7 pages March 13, 2017 Jigar Raythatha Dear Jigar, It Is My Pleasure to Offer to You the Position of President & CEO at Constellation Pharmaceuticals, Inc. (“The Company”). This Letter and Accompanying Enclosures Will Summarize the Terms of Your Employment, Should You Accept Our Offer

from S-1 122 pages Lease Agreement

from S-1 12 pages This Warrant and the Shares of Common Stock Issued Upon Its Exercise Have Not Been Registered Under the Securities Act of 1933, as Amended, or Any Applicable State Securities Laws and May Not Be Sold or Transferred Without Compliance With the Registration or Qualification Provisions of Applicable Federal and State Securities Laws or Applicable Exemptions Therefrom This Warrant and the Shares of Common Stock Issued Upon Its Exercise Are Subject to the Restrictions on Transfer Set Forth in Section 5 of This Warrant and the Second Series B Preferred Stock and Warrant Purchase Agreement, an Amended and Restated Investors’ Rights Agreement, as Amended, an Amended and Restated Stockholders’ Voting Agreement, as Amended and an Amended and Restated Right of First Refusal and Co-Sale Agreement, as Amended, Between the Company and the Holder of This Warrant

from S-1 13 pages Warrant to Purchase Stock